Abstract
Background: CLN2 disease is an autosomal recessively inherited storage disorder caused by deficient activity of the lysosomal enzyme tripeptidyl peptidase 1 (TPP1). The late infantile phenotype is characterized by rapid psychomotor decline and epilepsy. Early diagnosis and exact knowledge of the natural clinical course are important for evaluating experimental therapies.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
